Evidence map›Paper›PMID 33406698›Full record

ArticleVaccines2021

Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients.

Lise Boey, Eline Bosmans, Liane Braz Ferreira, Nathalie Heyvaert, Melissa Nelen, Lisa Smans, Hanne Tuerlinckx, Mathieu Roelants, Kathleen Claes, Inge Derdelinckx and 6 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Lise BoeyDepartment of Public Health and Primary Care, Leuven University Vaccinology Center, KU Leuven, Kapucijnenvoer 35, P.O. Box 7001, 3000 Leuven, Belgium.ORCID 0000-0001-9623-4482
Eline BosmansDepartment of Public Health and Primary Care, Leuven University Vaccinology Center, KU Leuven, Kapucijnenvoer 35, P.O. Box 7001, 3000 Leuven, Belgium.
Liane Braz FerreiraDepartment of Public Health and Primary Care, Leuven University Vaccinology Center, KU Leuven, Kapucijnenvoer 35, P.O. Box 7001, 3000 Leuven, Belgium.
Nathalie HeyvaertDepartment of Public Health and Primary Care, Leuven University Vaccinology Center, KU Leuven, Kapucijnenvoer 35, P.O. Box 7001, 3000 Leuven, Belgium.
Melissa NelenDepartment of Public Health and Primary Care, Leuven University Vaccinology Center, KU Leuven, Kapucijnenvoer 35, P.O. Box 7001, 3000 Leuven, Belgium.
Lisa SmansDepartment of Public Health and Primary Care, Leuven University Vaccinology Center, KU Leuven, Kapucijnenvoer 35, P.O. Box 7001, 3000 Leuven, Belgium.
Hanne TuerlinckxDepartment of Public Health and Primary Care, Leuven University Vaccinology Center, KU Leuven, Kapucijnenvoer 35, P.O. Box 7001, 3000 Leuven, Belgium.
Mathieu RoelantsEnvironment and Health, Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 35, P.O. Box 7001, 3000 Leuven, Belgium.ORCID 0000-0002-3749-0475
Kathleen ClaesDepartment of Nephrology and Renal Transplantation, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.ORCID 0000-0001-8510-2345
Inge DerdelinckxDepartment of General Internal Medicine, University Hospitals of Leuven, Herestraat 49, 3000 Leuven, Belgium.
Wim JanssensDepartment of Respiratory Diseases, University Hospitals of Leuven, Herestraat 49, 3000 Leuven, Belgium.ORCID 0000-0003-1830-2982
Chantal MathieuDepartment of Endocrinology, University Hospitals of Leuven, Herestraat 49, 3000 Leuven, Belgium.
Johan Van CleemputDepartment of Cardiology, University Hospitals of Leuven, Herestraat 49, 3000 Leuven, Belgium.
Robin VosDepartment of Respiratory Diseases-Lung Transplantation Unit, University Hospitals of Leuven, Herestraat 49, 3000 Leuven, Belgium.ORCID 0000-0002-3468-9251
Isabelle DesombereNRC Bordetella Pertussis and NRC Toxigenic Corynebacteria, Sciensano (Public Health Belgium), Engelandstraat 642, 1180 Ukkel, Belgium.
Corinne VandermeulenDepartment of Public Health and Primary Care, Leuven University Vaccinology Center, KU Leuven, Kapucijnenvoer 35, P.O. Box 7001, 3000 Leuven, Belgium.ORCID 0000-0002-1954-7554
KU Leuven · BESciensano (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with chronic diseases are at increased risk of complications following infection. It remains, however, unknown to what extend they are protected against vaccine-preventable diseases. We assessed seroprevalence of antibodies against diphtheria, tetanus and pertussis to evaluate whether current vaccination programs in Belgium are adequate. Antibody titers were assessed with a bead-based multiplex assay in serum of 1052 adults with chronic diseases. We included patients with diabetes mellitus type 1 (DM1) (

Indexed as

diphtheriapatientspertussisseroprevalencetetanus

Identifiers

PMID33406698
PMCPMC7824683
OpenAlexW3119577593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.